Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Tricare protocols require patients to use the anti-obesity medication phentermine before others - also approved by the FDA - ...

SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...

as well as the possibility of an oral medication trial and/or lifestyle intervention before more costly anti-obesity medications are introduced. Furthermore, the assessment suggests timing for ...

Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing ...

I am 5 weeks into Mounjaro, the weekly injectable medication that contains Tirzepatide, an active ingredient that supresses and regulates your appetite. Ozempic is perhaps the more famous ...

A woman on weight loss medication has called Health Secretary Wes Streeting "naive" for suggesting that weight-loss injections could be offered to jobless individuals to aid their return to work.

“A lot of insurance companies do not cover anti-obesity medication. That’s the big deal. We don’t have access,” said Apovian. At her clinic, Barenbaum describes prescribing some GLP-1s off ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such ... or GLP-1 medication for weight loss, surged by more than 130% ...

Tricare protocols require patients to use the anti-obesity medication phentermine before others — also approved by the FDA — can be prescribed. “It’s not as simple [as having] a provider ...